NEW YORK ( TheStreet) -- Meridian Bioscience (Nasdaq: VIVO) hit a new 52-week high Friday as it is currently trading at $26.51, above its previous 52-week high of $26.41 with 120,020 shares traded as of 10:02 a.m. ET. Average volume has been 189,600 shares over the past 30 days. Meridian Bioscience has a market cap of $1.1 billion and is part of the health care sector and drugs industry. Shares are up 11.1% year to date as of the close of trading on Thursday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. The company has a P/E ratio of 42.5, above the average drugs industry P/E ratio of 41.8 and above the S&P 500 P/E ratio of 17.7.
- Practice your VIVO trading strategies and win cash in our stock game.